Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy?
about
Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failureNa+/Ca2+ exchange and Na+/K+-ATPase in the heartPhospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality.Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.Electrical and structural remodeling in left ventricular hypertrophy-a substrate for a decrease in QRS voltage?Recovery of the failing heart: emerging approaches and mechanisms in excitation-contraction couplingEHD3-dependent endosome pathway regulates cardiac membrane excitability and physiology.Deciphering ryanodine receptor array operation in cardiac myocytes.Subcellular heterogeneity of ryanodine receptor properties in ventricular myocytes with low T-tubule densityOverexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress.Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitationDifferential regulation of EHD3 in human and mammalian heart failure.Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.The therapeutic potential of new insights into myocardial excitation-contraction coupling.Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.Molecular determinants of altered contractility in heart failure.Disruption of Ah Receptor Signaling during Mouse Development Leads to Abnormal Cardiac Structure and Function in the Adult.MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy.Constitutive overexpression of phosphomimetic phospholemman S68E mutant results in arrhythmias, early mortality, and heart failure: potential involvement of Na+/Ca2+ exchanger.Mathematical modeling mechanisms of arrhythmias in transgenic mouse heart overexpressing TNF-αHypertrophy and heart failure in mice overexpressing the cardiac sodium-calcium exchangerPalmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signalingSimulation of arrhythmogenic effect of rogue RyRs in failing heart by using a coupled modelInduced overexpression of Na(+)/Ca(2+) exchanger does not aggravate myocardial dysfunction induced by transverse aortic constriction.Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytesGene structure evolution of the Na+-Ca2+ exchanger (NCX) family.Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heartProtein Phosphatase 1c Associated with the Cardiac Sodium Calcium Exchanger 1 Regulates Its Activity by Dephosphorylating Serine 68-phosphorylated Phospholemman.Excitation-contraction coupling and mitochondrial energetics.Emerging mechanisms of T-tubule remodelling in heart failure.Regulation of intracellular and mitochondrial sodium in health and disease.Structure and dynamics of Ca2+-binding domain 1 of the Na+/Ca2+ exchanger in the presence and in the absence of Ca2+Regulation of the Na+/Ca2+ exchanger by pyridine nucleotide redox potential in ventricular myocytesSarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.Induced overexpression of Na+/Ca2+ exchanger transgene: altered myocyte contractility, [Ca2+]i transients, SR Ca2+ contents, and action potential duration.Designing heart performance by gene transfer.Calcium handling precedes cardiac differentiation to initiate the first heartbeatChronic administration of KB-R7943 induces up-regulation of cardiac NCX1.
P2860
Q26850165-2AB1A4CC-E6E1-4877-A76D-3930F1F2D686Q28258875-BEEDB3C1-7A4A-41B9-A1DB-5F56330E30AFQ30415311-6699D8FA-16CC-4C26-B577-D47020B393BEQ30867239-CF6E3B76-DF0F-49E4-BA75-C394B9777210Q33290232-28AF6001-46EB-4DC6-BE35-29E0701D3F63Q33715192-DD0D33E7-DF33-4EC4-AE6A-58E615FDE02BQ33787435-D9EF18FA-6E60-41D5-A040-3DE607464656Q34028261-997EAA8E-A2B4-4FE5-B579-A615A0D3DCE8Q34055517-38ECD128-A74F-40C2-90C8-015BAEE58A41Q34082800-917115E7-8A15-4D0E-8A1F-5C9CA3B23FF1Q34130135-BC2AC606-0B74-4A3A-95EB-B0BE82537F2FQ34260282-452ABE80-73DB-4A47-A35C-84DFA65100B7Q34700436-3CC4E8AC-15FD-4530-B412-1D78DA1A2450Q34973489-7EA8989B-BF03-404E-A9E9-7D0EB87E94DEQ35086109-5E6716AD-0C74-4FD2-9E99-09E328054952Q35116100-859C6936-12B7-4BB6-AF81-BCFD5A782B56Q35791489-63390A55-2D14-47F0-89FB-C7DE7F487D98Q35837597-E9577027-2DCA-4C1F-A434-6BC2D52A4703Q35858066-A4235C98-A34A-4E68-964C-DF67B7B8082DQ35916746-D0C426C5-9EE8-4DF8-9E31-33721A3A0494Q35964980-C47AB9F1-6DB7-40C3-B4EF-27292A8F85F1Q35989007-2A7945EA-B3AA-48E9-AD1A-16C3303F7CF6Q36057495-C62ABB2A-61A4-4D9D-9A05-ED93444ED588Q36171335-48DB0F59-C9E1-4900-BFF7-076687FC172CQ36302400-162E5E6D-8965-4A13-AB1B-421DC6392141Q36501450-DBBA82A9-433D-4908-8563-163FC7B85BF6Q36511011-C9F75882-D546-4AE6-BFA5-F69F3789087FQ36691410-0B19D520-CBAB-4DDF-BBD3-BBF95BDEEB01Q36735834-72E7D54A-0CAF-48C9-9902-BE2DC1741F88Q36744537-E1E9D631-731E-4863-9FE3-FC81C4FDCB8DQ36893596-9A0BB519-BEE2-4328-8CD5-ABB92C6105B0Q36968869-067C4385-58C3-4C64-A5EA-7242D2102E04Q37143058-6A2A028C-90C8-4792-8FAD-102D4D956814Q37243184-6334075F-314F-4ED7-AFB7-987AAB734D26Q37272198-20507378-2AF3-4168-AF93-91F139CD0B20Q37276399-2B6CFE6D-E739-4965-8082-E88971FBC766Q37298277-B8BE29D4-B69B-42A9-A466-C7B4BF311BE9Q37299072-5BC53BF8-CB28-43F8-9E50-620281DECD89Q37329059-0F447ABE-87E9-4949-804F-547A4651B11CQ37447977-F4313D1C-8C34-4322-AEC2-B3BA57C91484
P2860
Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@ast
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@en
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@nl
type
label
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@ast
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@en
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@nl
prefLabel
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@ast
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@en
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@nl
P2093
P1476
Altered Na/Ca exchange activit ...... ure: a new target for therapy?
@en
P2093
Fons Verdonck
Karin R Sipido
Marc A Vos
Paul G A Volders
P304
P356
10.1016/S0008-6363(01)00470-9
P577
2002-03-01T00:00:00Z